Thus, we established a predictive model of RCC that combined the nuclear localization of HIF-1α and CXCR4 together with the TNM stage, which is the most commonly used parameter in the clinic to determine patient prognosis. This evidence concerns the gene HIF1A and renal cell carcinoma.